Topic Hub
11 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 11 of 11 clinical reviews.
Why AndroGel (testosterone topical) causes gynecomastia, when breast tissue growth becomes permanent, and evidence-based strategies for management including aromatase inhibitors and surgery.
Read clinical reviewEvidence-based dietary strategies to reduce gynecomastia risk while on AndroGel (testosterone topical), including anti-aromatase foods, nutrients, and what to avoid.
Read clinical reviewSpecific dietary, hydration, meal-timing, and lifestyle strategies that reduce aromatization-driven gynecomastia in men on AndroGel testosterone gel. Evidence-based, clinically actionable.
Read clinical reviewHow common is gynecomastia on AndroGel, how severe does it get, who is most at risk, and what does resolution actually look like? Evidence-anchored answers from TRT trial data and endocrine management literature.
Read clinical reviewA clinically specific, week-by-week breakdown of when gynecomastia starts, peaks, and resolves on AndroGel testosterone therapy, with trial data and actionable management at each phase.
Read clinical reviewA clinician-grade, step-by-step protocol for assessing and managing gynecomastia in patients using AndroGel (testosterone topical), covering aromatization mechanics, grading, first-line interventions, escalation criteria, and discontinuation thresholds.
Read clinical reviewA clinical deep-dive on OTC and prescription options for managing gynecomastia caused by AndroGel testosterone therapy, including dose ranges, drug interactions, and when to escalate care.
Read clinical reviewA clinical deep-dive on how slowing titration, pausing, stepping down, and microdosing AndroGel can resolve gynecomastia caused by excess aromatization. Real protocols, when each works, and when to escalate.
Read clinical reviewA clinical threshold guide for patients and prescribers: when gynecomastia from AndroGel warrants dose adjustment, medical intervention, or outright discontinuation, with criteria for switching to alternative TRT formulations.
Read clinical reviewA clinical-grade explanation of how AndroGel's testosterone aromatizes into estradiol, why breast tissue responds, and what patients and prescribers can do about it right now.
Read clinical reviewAndroGel (testosterone topical) can cause gynecomastia through aromatization, the enzymatic conversion of testosterone to estradiol. Learn the biology, risk factors, and clinical management.
Read clinical review